CTLA4 and lung cancer: The previous study indicated that CTLA4 was highly expressed and positively correlated with the clinical stage of non‐small cell lung cancer,27 and CTLA4 blockade could promote the infiltration of immune cells and derived loss of Treg stability in glycolysis‐low tumor.28